Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,0001 USD | +9.900,00 % | -.--% | -66,67 % |
Resumen de negocios
Ventas por actividad
USD en millones | 2020 | Peso | 2021 | Peso | Delta |
---|---|---|---|---|---|
Clinic Testing
92,6
%
| 1 | 20,5 % | 22 | 92,6 % | +4.049,80 % |
Cannaboid Products
3,8
%
| 2 | 64,5 % | 1 | 3,8 % | -45,40 % |
Wholesale
2,4
%
| 0 | 2,2 % | 1 | 2,4 % | +883,77 % |
Cannaboid Testing
1,2
%
| 0 | 12,8 % | 0 | 1,2 % | -16,19 % |
Ventas por región
USD en millones | 2020 | Peso | 2021 | Peso | Delta |
---|---|---|---|---|---|
United Kingdom
100,0
%
| 3 | 100,0 % | 23 | 100,0 % | +817,37 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
George Thomas
CEO | Chief Executive Officer | 35 | 26/01/21 |
Geremy Thomas
FOU | Founder | 64 | 14/02/11 |
John Pettit
CTO | Chief Tech/Sci/R&D Officer | - | - |
Emily Critchley
HRO | Human Resources Officer | - | - |
Paul van Issum
PRN | Corporate Officer/Principal | - | - |
Anne Tew
SEC | Corporate Secretary | - | 01/11/18 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Geremy Thomas
FOU | Founder | 64 | 14/02/11 |
George Thomas
CEO | Chief Executive Officer | 35 | 26/01/21 |
Anne Tew
SEC | Corporate Secretary | - | 01/11/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 364 962 760 | 256 430 105 ( 70,26 %) | 0 | 70,26 % |
Información de la empresa
Empresas del grupo
Nombre | Categoría y sector |
---|---|
Sativa Group Plc
Sativa Group Plc Financial ConglomeratesFinance Sativa Group Plc engages in the production, testing and compliance, commercialization, sales, and marketing of cannabidiol products. It operates through the following segments: Products; Testing; and Extraction and Research and Development. The Products segment focuses in the sale of cannabidiol products. The Testing segment involves in testing cannabidiol products. The Extraction and Research and Development segment include extraction and research and development operations which develops future products. The company was founded by Geremy Howard Prance Thomas on December 19, 2017 and is headquartered in London, the United Kingdom. |
Financial Conglomerates
|
Ventas por actividad
Chiffre d''affaires - Tasa de sorpresa
Varia. 1 de ene. | Capi. | |
---|---|---|
-66,67 % | 3,65 mil | |
+42,38 % | 6261,52 M | |
-15,86 % | 4490,29 M | |
+6,36 % | 3285,57 M | |
-11,28 % | 3123,64 M | |
-3,23 % | 2496,83 M | |
+45,24 % | 1940,45 M | |
-7,89 % | 1684,98 M | |
-0,98 % | 1634,88 M | |
-11,32 % | 1564,08 M |
- Bolsa de valores
- Acciones
- Acción GDBYF
- Empresa Goodbody Health Limited